Off-label use of direct oral anticoagulants in patients receiving surgical mechanical and bioprosthetic heart valves

Authors

Ankur Kalra, Cleveland Clinic, Cleveland, Ohio
Sajjad Raza, Cleveland Scientific Consulting, Cleveland, Ohio
Baqir Hasan Jafry, Aga Khan UniversityFollow
Harley E. King, Cleveland Clinic Akron General, Akron, Ohio
Joseph A. Lahorra, Cleveland Clinic Akron General, Akron, Ohio
Lars G. Svensson, Cleveland Clinic, Cleveland, Ohio
Samir R. Kapadia, Cleveland Clinic, Cleveland, Ohio

Document Type

Article

Abstract

This cohort study assesses direct oral anticoagulant use in patients with surgical prosthetic heart valves in the United States and evaluates differences in preoperative and postoperative profiles in patients discharged while receiving direct oral anticoagulant vs warfarin.

Comments

Pagination are not provided by the author/publisher

Publication (Name of Journal)

JAMA Network Open

Recommended Citation

Kalra, A., Raza, S., Jafry, B. H., King, H. E., Lahorra, J. A., Svensson, L. G., Kapadia, S. R. (2021). Off-label use of direct oral anticoagulants in patients receiving surgical mechanical and bioprosthetic heart valves. JAMA Network Open, 4(3), e211259.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_mc/190

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.